摘要:This paper introduced the present situation and development of autologous stem cell therapy about lower limb ischemia,including the current mainstream therapy of autologous bone marrow stem cells,autologous peripheral blood stem cells and improved bone marrow stem cells,also explained the Chinese government’s policies about stem cell treatment,and brought up his own views about the direction of clinical conversion in this field.
Lan Xie,Yong Guo,Guo-liang Huang,Wan-li Xing,Hua-fang Gao,Ling-xiang Zhu,Dong Wang,Guan-bin Zhang,Yi-min Sun,Zhi-wei Zhang,Can Wang,Gao-shan Jing,Wen-yan Qin,Keith Mitchelson,Yu-xiang Zhou,Jing Cheng. Advances in translational medicine for individualized diagnosis of diseases[J]. Translational Medicine Research (Electronic Edition), 2011, 1(1): 46-68.